Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma

NCT03777475 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03777475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03777475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2016
Completion date
December 31, 2022
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma